Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA
Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA
批准号:
9125539
负责人:
David J Erle
金额:
$7.93万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2016-04-30
关键词:
AdultAgeAmniotic FluidBase SequenceBioinformaticsBiological MarkersBloodBody FluidsBronchoalveolar LavageCellsCerebrospinal FluidChildChildhoodClinicalCohort StudiesCollaborationsCommunication ProgramsConsultationsDataDevelopmentDiagnosticDiseaseEmbryonic FluidEnrollmentEpidemiologic StudiesEthnic OriginFemaleFractionationFundingGALAGenderGene Expression ProfileGenomicsGoalsHealthHumanHuman bodyHydrolysisInfectionInflammationInterdisciplinary StudyLaboratoriesLibrariesLiquid substanceMalignant NeoplasmsMetadataMethodsOvarian FollicleParticipantPatientsPhasePlasmaPopulationPopulation HeterogeneityPreparationProductionPublic HealthRNARNA SequencesReference ValuesResearch PersonnelResearch Project GrantsRibonucleasesRoboticsSalivaSamplingSeminal fluidSiteSmall RNASourceSputumTechnologyTherapeuticUmbilical Cord BloodUnited States National Institutes of HealthUniversitiesUntranslated RNAUrineWorkbasecircular RNAclinical investigationdata sharingdisorder riskexperienceextracellularinsightinterestmalemetagenomemicrobialmultidisciplinaryphase 1 studypublic health relevancesexstatisticstranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Our goal is to generate reference profiles of short, long and circular non-coding regulatory exRNAs, including environmentally-derived exRNAs, in samples of 12 different body fluids from healthy humans using comprehensive RNA sequencing. We have assembled a multidisciplinary team with expertise in clinical investigation, genomics technologies, bioinformatics and statistics
to achieve this goal. One major strength of this proposal is that we benefit from close interactions with other investigators participating in two UCSF-based U19 projects supported by the Common Fund Extracellular RNA Communication Program. Another major strength is that we will make use of very large sets of carefully curated body fluid samples collected from ethnically diverse populations of female and male children and adults who participated in NIH-funded cohort studies. Our three specific aims are: Aim 1) Obtain a large and diverse set of samples from 12 human body fluids (plasma, serum, cord blood, urine, cerebrospinal fluid (CSF), sputum, bronchoalveolar lavage (BAL), saliva, seminal fluid, amniotic fluid, peri-embryonic fluid and ovarian follicle fluid), Aim 2) Use state of the art approaches to sequence the full range of exRNAs in body fluid samples, and Aim 3) Apply appropriate analytical approaches to identify human and exogenous RNAs and establish normal reference values for representative ethnically-diverse US populations. We will approach the project in two phases. In phase I (years 1-2), we will study ~200 samples representing 12 body fluids using three complementary sequencing approaches. These studies will fill major gaps in our understanding of the diversity of exRNAs in human body fluids and provide important insights about which sequencing-based approaches are most valuable for exRNA identification and quantification. During phase II (years 3-5), we will build on our phase I studies and other work performed by Extracellular RNA Communication Program participants by analyzing 2,880 plasma and urine samples that have been banked from 2,160 subjects enrolled in three large, ethnically-diverse, NIH cohort studies (CARDIA, REGARDS and GALA/SAGE). These studies will be adequately powered to establish normal reference ranges for exRNAs stratified by age, sex, and ethnicity. Each phase is associated with realistic milestone assessments and can form the basis for collaboration with other consortium participants. This project is relevant to public health in thatit will establish the healthy control reference data necessary to apply exRNAs as biomarkers in patients with or at risk for disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Asthma Endotypes: Mechanisms and Consequences for Airway Epithelium and Mucus
-
批准号:10371127
-
项目类别:
-
资助金额:$179.79万
-
财政年份:2020
-
负责人:David J Erle
-
依托单位:
Administrative Core
-
批准号:10371122
-
项目类别:
-
资助金额:$8.11万
-
财政年份:2020
-
负责人:David J Erle
-
依托单位:
Understanding Asthma Endotypes
-
批准号:10165891
-
项目类别:
-
资助金额:$288.82万
-
财政年份:2020
-
负责人:David J Erle
-
依托单位:
Understanding Asthma Endotypes
-
批准号:10165887
-
项目类别:
-
资助金额:$55.17万
-
财政年份:2020
-
负责人:David J Erle
-
依托单位:
Airway epithelial cell gene regulation: new mechanisms and therapeutic strategies
-
批准号:10586412
-
项目类别:
-
资助金额:$9.43万
-
财政年份:2019
-
负责人:David J Erle
-
依托单位:
Airway epithelial cell gene regulation: new mechanisms and therapeutic strategies
-
批准号:10579268
-
项目类别:
-
资助金额:$96.9万
-
财政年份:2019
-
负责人:David J Erle
-
依托单位:
Airway epithelial cell gene regulation: new mechanisms and therapeutic strategies
-
批准号:9915971
-
项目类别:
-
资助金额:$96.69万
-
财政年份:2019
-
负责人:David J Erle
-
依托单位:
Airway epithelial cell gene regulation: new mechanisms and therapeutic strategies
-
批准号:10349455
-
项目类别:
-
资助金额:$96.9万
-
财政年份:2019
-
负责人:David J Erle
-
依托单位:
Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA
-
批准号:8775079
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2014
-
负责人:David J Erle
-
依托单位:
Massively parallel identification of functional 3' UTR variants in asthma
-
批准号:8901295
-
项目类别:
-
资助金额:$54.87万
-
财政年份:2014
-
负责人:David J Erle
-
依托单位:
Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA
-
批准号:9449991
-
项目类别:
-
资助金额:$4.21万
-
财政年份:2014
-
负责人:David J Erle
-
依托单位:
Empiric deconvolution of functional RNA elements
-
批准号:9250163
-
项目类别:
-
资助金额:$52.49万
-
财政年份:2014
-
负责人:David J Erle
-
依托单位:
Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA
-
批准号:8897440
-
项目类别:
-
资助金额:$67.7万
-
财政年份:2014
-
负责人:David J Erle
-
依托单位:
Empiric deconvolution of functional RNA elements
-
批准号:8675066
-
项目类别:
-
资助金额:$56.06万
-
财政年份:2014
-
负责人:David J Erle
-
依托单位:
Massively parallel identification of functional 3' UTR variants in asthma
-
批准号:9278264
-
项目类别:
-
资助金额:$55.42万
-
财政年份:2014
-
负责人:David J Erle
-
依托单位:
Empiric deconvolution of functional RNA elements
-
批准号:9068289
-
项目类别:
-
资助金额:$52.53万
-
财政年份:2014
-
负责人:David J Erle
-
依托单位:
Massively parallel identification of functional 3' UTR variants in asthma
-
批准号:8768151
-
项目类别:
-
资助金额:$54.28万
-
财政年份:2014
-
负责人:David J Erle
-
依托单位:
Micro-RNAs in airway epithelial differentiation and asthma
-
批准号:8131328
-
项目类别:
-
资助金额:$22.33万
-
财政年份:2011
-
负责人:David J Erle
-
依托单位:
Micro-RNAs in airway epithelial differentiation and asthma
-
批准号:8253704
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2011
-
负责人:David J Erle
-
依托单位:
Specialized molecules with essential roles in mucus production
-
批准号:8010842
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2010
-
负责人:David J Erle
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: